{"id":48117,"date":"2020-12-04T11:26:41","date_gmt":"2020-12-04T16:26:41","guid":{"rendered":"https:\/\/www.med.unc.edu\/medicine\/?p=48117"},"modified":"2023-06-06T18:03:10","modified_gmt":"2023-06-06T22:03:10","slug":"precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer","status":"publish","type":"post","link":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/","title":{"rendered":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer"},"content":{"rendered":"<figure id=\"attachment_48118\" class=\"thumbnail wp-caption alignright\" style=\"width: 210px\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-48118\" src=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC-200x300.jpg\" alt=\"Lisa-Carey-LCCC\" width=\"200\" height=\"300\" srcset=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC-200x300.jpg 200w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC-301x452.jpg 301w, https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg 600w\" sizes=\"auto, (max-width: 200px) 100vw, 200px\" \/><figcaption class=\"caption wp-caption-text\">Lisa Carey, MD, FASCO<\/figcaption><\/figure>\n<p>Women with a particularly aggressive form of breast cancer, known as HER2-positive disease, now have unique options that can help tailor their treatment more effectively. Based on results from a phase III clinical trial that followed women for seven years and was conducted at the UNC Lineberger Comprehensive Cancer Center and other cancer centers nationwide, a new therapeutic roadmap may help clinicians figure out which tumors can be treated less aggressively. The findings were published in the\u00a0<a href=\"https:\/\/ascopubs.org\/doi\/full\/10.1200\/JCO.20.01276\"><em>Journal of Clinical Oncology<\/em><\/a>.<\/p>\n<p>Human epidermal growth factor receptor 2 (HER2) positivity is found in 15% to 20% of breast cancers. The American Cancer Society predicts nearly 280,000 people in the U.S. will be diagnosed with breast cancer this year. Herceptin (trastuzumab), the first anti-HER2 targeted therapy, was approved by the Food and Drug Administration in 1998 and greatly improved chances of survival in women with HER2-positive disease. However, there are multiple molecular subtypes of HER2-positive breast cancer, each of which responds to treatment differently.<\/p>\n<p>\u201cThere is substantial variability in this type of breast cancer from the standpoint of responsiveness to drugs and risk of relapse, so our research helps shine a light on that variability,\u201d said Lisa A. Carey, MD, FASCO, deputy director of clinical science and the Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research at UNC Lineberger. \u201cIn the future, we will not treat every woman in the same manner. This is what precision medicine is about \u2014 the right drugs for the right patient, with the corollary of not giving unnecessary drugs to those who don\u2019t need them.\u201d<\/p>\n<p>Read more from the <a href=\"https:\/\/unclineberger.org\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\">UNC Lineberger Comprehensive Cancer Center<\/a>.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Women with a particularly aggressive form of breast cancer, known as HER2-positive disease, now have unique options that can help tailor their treatment more effectively. Based on results from a phase III clinical trial that followed women for seven years and was conducted at the UNC Lineberger Comprehensive Cancer Center and other cancer centers nationwide, &hellip; <a href=\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\" aria-label=\"Read more about Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer\">Read more<\/a><\/p>\n","protected":false},"author":69419,"featured_media":48118,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"layout":"","cellInformation":"","apiCallInformation":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,517],"tags":[629],"class_list":["post-48117","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-oncology","tag-629","odd"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine\" \/>\n<meta property=\"og:description\" content=\"Women with a particularly aggressive form of breast cancer, known as HER2-positive disease, now have unique options that can help tailor their treatment more effectively. Based on results from a phase III clinical trial that followed women for seven years and was conducted at the UNC Lineberger Comprehensive Cancer Center and other cancer centers nationwide, &hellip; Read more\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Department of Medicine\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/UNCDeptMedicine\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-04T16:26:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-06T22:03:10+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"600\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Kim Morris\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:site\" content=\"@uncdeptmedicine\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Kim Morris\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\"},\"author\":{\"name\":\"Kim Morris\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"headline\":\"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer\",\"datePublished\":\"2020-12-04T16:26:41+00:00\",\"dateModified\":\"2023-06-06T22:03:10+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg\",\"keywords\":[\"2020\"],\"articleSection\":[\"News\",\"Oncology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\",\"name\":\"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine\",\"isPartOf\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg\",\"datePublished\":\"2020-12-04T16:26:41+00:00\",\"dateModified\":\"2023-06-06T22:03:10+00:00\",\"author\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg\",\"contentUrl\":\"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg\",\"width\":600,\"height\":900,\"caption\":\"Lisa Carey, MD, FASCO\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.med.unc.edu\/medicine\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#website\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/\",\"name\":\"Department of Medicine\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529\",\"name\":\"Kim Morris\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g\",\"caption\":\"Kim Morris\"},\"description\":\"Medicine - Dept of\",\"url\":\"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/","og_locale":"en_US","og_type":"article","og_title":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine","og_description":"Women with a particularly aggressive form of breast cancer, known as HER2-positive disease, now have unique options that can help tailor their treatment more effectively. Based on results from a phase III clinical trial that followed women for seven years and was conducted at the UNC Lineberger Comprehensive Cancer Center and other cancer centers nationwide, &hellip; Read more","og_url":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/","og_site_name":"Department of Medicine","article_publisher":"https:\/\/www.facebook.com\/UNCDeptMedicine","article_published_time":"2020-12-04T16:26:41+00:00","article_modified_time":"2023-06-06T22:03:10+00:00","og_image":[{"width":600,"height":900,"url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","type":"image\/jpeg"}],"author":"Kim Morris","twitter_card":"summary_large_image","twitter_creator":"@uncdeptmedicine","twitter_site":"@uncdeptmedicine","twitter_misc":{"Written by":"Kim Morris","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#article","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/"},"author":{"name":"Kim Morris","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"headline":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer","datePublished":"2020-12-04T16:26:41+00:00","dateModified":"2023-06-06T22:03:10+00:00","mainEntityOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/"},"wordCount":294,"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","keywords":["2020"],"articleSection":["News","Oncology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/","url":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/","name":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer | Department of Medicine","isPartOf":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","datePublished":"2020-12-04T16:26:41+00:00","dateModified":"2023-06-06T22:03:10+00:00","author":{"@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529"},"breadcrumb":{"@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#primaryimage","url":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","contentUrl":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","width":600,"height":900,"caption":"Lisa Carey, MD, FASCO"},{"@type":"BreadcrumbList","@id":"https:\/\/www.med.unc.edu\/medicine\/news\/precision-treatment-advances-improve-survival-in-women-with-aggressive-her2-breast-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.med.unc.edu\/medicine\/"},{"@type":"ListItem","position":2,"name":"Precision Treatment Advances Improve Survival in Women With Aggressive HER2+ Breast Cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.med.unc.edu\/medicine\/#website","url":"https:\/\/www.med.unc.edu\/medicine\/","name":"Department of Medicine","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.med.unc.edu\/medicine\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/9a358414a53d5237f9ba3f8daa55c529","name":"Kim Morris","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.med.unc.edu\/medicine\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/95c34b3e4d55a602b94260bccc6350c2ddfdde901530a734fe6c8fa9e3a5d399?s=96&d=mm&r=g","caption":"Kim Morris"},"description":"Medicine - Dept of","url":"https:\/\/www.med.unc.edu\/medicine\/news\/author\/kcmorris\/"}]}},"featured_image":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","featured_image_medium":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC-200x300.jpg","featured_image_medium_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","featured_image_large":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC.jpg","featured_image_thumbnail":"https:\/\/www.med.unc.edu\/medicine\/wp-content\/uploads\/sites\/945\/2020\/12\/Lisa-Carey-LCCC-150x150.jpg","featured_image_alt":"Lisa-Carey-LCCC-ASCO-Recorded-Discussion","category_details":[{"name":"News","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/news\/"},{"name":"Oncology","link":"https:\/\/www.med.unc.edu\/medicine\/news\/category\/oncology\/"}],"tag_details":[{"name":"2020","link":"https:\/\/www.med.unc.edu\/medicine\/news\/tag\/2020\/"}],"_links_to":[],"_links_to_target":[],"_links":{"self":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/48117","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/users\/69419"}],"replies":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/comments?post=48117"}],"version-history":[{"count":0,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/posts\/48117\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media\/48118"}],"wp:attachment":[{"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/media?parent=48117"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/categories?post=48117"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.med.unc.edu\/medicine\/wp-json\/wp\/v2\/tags?post=48117"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}